Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases.
about
Multi-modality treatment of colorectal liver metastasesLocoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey.Relative effectiveness and safety of chemotherapy in elderly and nonelderly patients with stage III colon cancer: a systematic review.Multidisciplinary approach of colorectal cancer liver metastases.The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer.Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer.Colorectal hepatic metastasis: Evolving therapies.Current state of surgical treatment of liver metastases from colorectal cancerThe role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis.Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis.Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey.Management of potentially resectable colorectal cancer liver metastasesDetermining timing of hepatectomy for colorectal cancer with distant metastasis according to imaging-based tumor shrinkage ratio.Prospective multicenter phase II clinical trial of FOLFIRI chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastasesClinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors.Meeting the biologic challenge of colorectal metastases.Management of colorectal cancer presenting with synchronous liver metastases.State of the art: colorectal liver metastases.Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.Postoperative complications affect long-term survival outcomes following hepatic resection for colorectal liver metastasis.Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease.Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer.Patient selection for the surgical treatment of resectable colorectal liver metastases.Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites.Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect?The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.Intercostal high intensity focused ultrasound for liver ablation: The influence of beam shaping on sonication efficacy and near-field risks.Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors.Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases.Is surgical resection justified for stage IV colorectal cancer patients having bilobar hepatic metastases?--an analysis of survival of 77 patients undergoing hepatectomy.[Current management of liver metastases from colorectal cancer: recommendations of the São Paulo Liver Club].Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease.Bevacizumab treatment before resection of colorectal liver metastases: safety, recovery of liver function, pathologic assessment.
P2860
Q27006832-3EB91AB9-467B-4B8E-927B-204646C19CE9Q30415022-48DC45F0-24E8-4E72-83CF-4E934D4D3FB8Q30930073-9E866E13-4BAD-48DD-B534-71C7BEC5437DQ33405177-B66AF542-D55F-4FCD-B95F-DF390C65ED32Q33779859-689F4D32-AF0B-4835-9E6A-61A8384BFF36Q33977304-C4BD69EA-7E73-470B-BD91-B99687752DE0Q34013522-74020EA9-2B25-43B9-B0AD-4BA8F9BD3B3DQ34658302-AD2E1ED2-9948-46BD-8EC9-C4DF61D965C2Q34663557-74226F33-6F6F-43AD-921B-E661BAE36454Q35653302-C729FF32-30A1-4560-BEB2-ECB4E124E761Q35988684-7A47C477-0EB0-4F1F-ACC2-8D82E0937FACQ36003241-5F0C89F3-7D1C-4CAA-8811-E0C1AABC1160Q36063262-92DB2210-3513-4A17-BF43-468A9DDA16CAQ36244515-940F1C73-1057-4F7A-81EC-9425AD1F8302Q36871770-0EC6230F-E378-448C-AEE8-E59759AD1E21Q37083909-C87D8C30-C021-4067-8779-C5C3F2DE523FQ37217358-CC4C2056-3870-41C4-B3AC-007EF2224485Q37308725-F3957D2C-9047-417A-BD7E-89B14AF375A7Q37500453-53114351-CB87-483F-B9D2-9FA6F50453FFQ37821836-9B886933-2010-4E96-B9E4-B17F5DC3FD42Q38051068-368583CB-C9C3-4D80-BE79-B78EBD9B4B65Q38217004-6422116F-892F-4040-8BA9-DEAA972610F8Q38283659-B1CBD559-F223-4D76-927A-9044FBCFB8C1Q38317344-4837D480-16E2-4A86-A9CE-F6868CB5740DQ38365286-DF4CABB1-1C7E-4A5B-8D58-D522EEDB4A4BQ38528849-AD2DE368-8969-4B44-9D96-73EA32D823EDQ38770147-00450996-98D0-4D2C-98A0-50C974E9E0B1Q38938329-34312C1B-DFA1-4017-842C-9F2446F61868Q38990110-B2916138-FABE-4698-BD27-0E8C46D8C142Q39455528-7928C776-201E-44DD-A946-440E7F8C094BQ39754325-97181D5C-C492-4255-85E2-3C05865F1537Q40561488-574CF548-B1E8-46C8-956A-2650DCA94AC3Q40670460-3F674CF8-FA58-4243-8082-918F1425C89BQ42592749-3E2B613C-06E1-4F8C-86F0-B78FA995D312Q43413801-771AD639-BABB-420C-AB49-B0EB3ECEA811Q43711263-D90D87C5-87F8-4250-8407-4ADAF6BFDD79Q43903459-C1D2500F-88E0-4046-B5B9-90599E1BFA31Q44537609-01B89344-42F2-4623-A15B-A98410990E68Q45141490-D1CD0D52-797D-4954-B94B-1BD5722BE07FQ46183954-445FA978-D288-4876-837B-A30CC8FB174F
P2860
Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review of randomize ...... e colorectal liver metastases.
@en
Systematic review of randomize ...... e colorectal liver metastases.
@nl
type
label
Systematic review of randomize ...... e colorectal liver metastases.
@en
Systematic review of randomize ...... e colorectal liver metastases.
@nl
prefLabel
Systematic review of randomize ...... e colorectal liver metastases.
@en
Systematic review of randomize ...... e colorectal liver metastases.
@nl
P2093
P1476
Systematic review of randomize ...... e colorectal liver metastases.
@en
P2093
Adel Kokandi
Akshat Saxena
David L Morris
Terence C Chua
Winston Liauw
P2888
P304
P356
10.1245/S10434-009-0781-1
P577
2009-10-24T00:00:00Z
P6179
1038080010